Delving deeper into the regulatory role of PARP9, its overexpression also mitigated the inhibiting impact of PFD on key fibrotic markers induced by Ang II, namely, collagen I, collagen III, α-SMA, CTGF, and fibronectin. The gene discussed is PARP9; the disease is polyostotic fibrous dysplasia.